Published in J Neurosci on February 19, 2014
PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes. Mol Brain (2016) 1.39
Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health. Antioxid Redox Signal (2015) 0.82
Exploring Internal Ribosome Entry Sites as Therapeutic Targets. Front Oncol (2015) 0.78
Lost in translation: miRNAs and mRNAs in ischemic preconditioning and ischemia/reperfusion injury. J Mol Cell Cardiol (2015) 0.78
Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease. Biochem J (2015) 0.78
Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett (2015) 0.78
Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network. Brain Res (2015) 0.76
Decoding Parkinson's Disease Pathogenesis: The Role of Deregulated mRNA Translation. J Parkinsons Dis (2016) 0.75
PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation. Exp Neurobiol (2016) 0.75
BNIP3 induction by hypoxia stimulates FASN-dependent free fatty acid production enhancing therapeutic potential of umbilical cord blood-derived human mesenchymal stem cells. Redox Biol (2017) 0.75
Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease. Neurochem Int (2017) 0.75
Xenopus laevis as a Model to Identify Translation Impairment. J Vis Exp (2015) 0.75
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem (1999) 14.59
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006) 11.91
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature (2006) 11.81
Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem (2008) 7.71
Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem (1996) 7.37
Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell (2010) 7.20
Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev (2001) 5.37
HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev (2009) 5.24
Integration of oxygen signaling at the consensus HRE. Sci STKE (2005) 4.95
Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol (2006) 4.71
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A (2008) 4.50
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A (2005) 4.22
Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell (2006) 4.20
The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev (2007) 4.13
PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol (2007) 3.86
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J (2008) 3.51
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest (2009) 3.17
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J (2007) 2.72
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A (2008) 2.64
Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell (2002) 2.61
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell (2007) 2.44
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J (2006) 2.41
HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci (2008) 2.37
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci (2009) 2.35
Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem (2008) 2.29
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet (2005) 2.28
4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family. J Biol Chem (1998) 2.17
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet (2011) 2.00
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm (Vienna) (2004) 1.89
Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol (2005) 1.81
A review of Parkinson's disease. Br Med Bull (2008) 1.78
Improved Phos-tag SDS-PAGE under neutral pH conditions for advanced protein phosphorylation profiling. Proteomics (2010) 1.70
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A (2004) 1.59
Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol Dis (2005) 1.57
Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A (2004) 1.47
Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol Cell (2010) 1.38
PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease. PLoS One (2009) 1.30
Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila. Hum Mol Genet (2010) 1.19
Reduction of protein translation and activation of autophagy protect against PINK1 pathogenesis in Drosophila melanogaster. PLoS Genet (2010) 1.14
Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis (2005) 1.12
Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease. J Cell Sci (2012) 1.11
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci (2007) 1.05
Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease. J Biol Chem (2009) 1.03
Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem (2004) 0.96
New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress. J Biol Chem (2010) 0.93
Inhibition of Cap-initiation complexes linked to a novel mechanism of eIF4G depletion in acute myocardial ischemia. Cell Death Differ (2006) 0.81
Hypoxia regulation of ATP13A2 (PARK9) gene transcription. J Neurochem (2012) 0.81
Retracted Expression of concern: Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med (2008) 3.93
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature (2002) 3.92
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest (2009) 3.17
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84
Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci (2004) 2.45
Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem (2008) 2.29
Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards. J Neurosci (2003) 2.00
Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem (2005) 1.75
Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci (2002) 1.75
Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice. Proc Natl Acad Sci U S A (2010) 1.74
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol (2007) 1.72
A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry (2009) 1.69
Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res Mol Brain Res (2003) 1.66
Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology (2005) 1.60
Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord (2006) 1.49
The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Exp Neurol (2003) 1.48
Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem (2006) 1.46
Transgenic mouse models of dopamine deficiency. Ann Neurol (2003) 1.45
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci (2008) 1.43
Dopamine scales performance in the absence of new learning. Neuron (2006) 1.35
Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol (2008) 1.34
Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry (2008) 1.31
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol (2005) 1.30
The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol Cell Neurosci (2005) 1.29
Education research: case logs in the assessment of medical students in the neurology outpatient clinic. Neurology (2014) 1.28
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry (2003) 1.28
Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. J Neurochem (2007) 1.22
Instrumental learning in hyperdopaminergic mice. Neurobiol Learn Mem (2006) 1.22
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells (2005) 1.22
Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology (2008) 1.18
Tonic dopamine modulates exploitation of reward learning. Front Behav Neurosci (2010) 1.17
Global regulation of mRNA translation and stability in the early Drosophila embryo by the Smaug RNA-binding protein. Genome Biol (2014) 1.15
Dopamine-dependent motor learning: insight into levodopa's long-duration response. Ann Neurol (2010) 1.12
Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci (2009) 1.11
Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression. BMC Neurosci (2007) 1.09
Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. J Parkinsons Dis (2012) 1.09
Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells (2006) 1.05
Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum Mol Genet (2007) 1.05
Low amplitude entrainment of mice and the impact of circadian phase on behavior tests. Physiol Behav (2006) 1.04
Taste uncoupled from nutrition fails to sustain the reinforcing properties of food. Eur J Neurosci (2012) 1.02
Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.01
Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources. Front Integr Neurosci (2012) 1.00
Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease. Acta Neuropathol (2013) 1.00
Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward. Neuropsychopharmacology (2007) 1.00
Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease. Neurobiol Dis (2007) 0.99
Student assessment by objective structured examination in a neurology clerkship. Neurology (2012) 0.96
Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem (2004) 0.96
Physiological hypoxia promotes survival of cultured cortical neurons. Eur J Neurosci (2005) 0.95
A cAMP pathway underlying reward prediction in associative learning. J Neurosci (2008) 0.95
Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila. J Biol Chem (2013) 0.94
Septic encephalopathy: inflammation in man and mouse. Neurochem Int (2011) 0.94
The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells. Mitochondrion (2011) 0.94
Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice. J Neurophysiol (2007) 0.93
MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Res (2007) 0.93
Sucrose exposure in early life alters adult motivation and weight gain. PLoS One (2008) 0.89
Structural determinants of PINK1 topology and dual subcellular distribution. BMC Cell Biol (2010) 0.88
Loss of cocaine locomotor response in Pitx3-deficient mice lacking a nigrostriatal pathway. Neuropsychopharmacology (2008) 0.88
A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. Cell Rep (2012) 0.88
The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport (2004) 0.87
Dopaminergic enhancement of local food-seeking is under global homeostatic control. Eur J Neurosci (2011) 0.85
Regulation of the noradrenaline neurotransmitter phenotype by the transcription factor AP-2beta. J Biol Chem (2008) 0.85
Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol (2010) 0.85
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. Acta Neuropathol Commun (2015) 0.84
A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes. J Neurosurg (2008) 0.84
The role of neuroplasticity in dopaminergic therapy for Parkinson disease. Nat Rev Neurol (2013) 0.83
Motivational effects on interval timing in dopamine transporter (DAT) knockdown mice. Brain Res (2010) 0.83
Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology (2012) 0.83
Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice. J Neurosci (2014) 0.83
The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. J Neurogenet (2014) 0.83
Ammonia-induced brain swelling and neurotoxicity in an organotypic slice model. Neurol Res (2011) 0.82
Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol (2013) 0.81
A molecular dissociation between cued and contextual appetitive learning. Learn Mem (2010) 0.81
Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats. J Neurosurg (2004) 0.81
Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery (2004) 0.81
Long-lived retrograde fluorescent labeling of corticospinal neurons in the living animal. Brain Res Brain Res Protoc (2004) 0.80
Adaptation to moderate hypoxia protects cortical neurons against ischemia-reperfusion injury and excitotoxicity independently of HIF-1α. Exp Neurol (2011) 0.80
Glutamate receptor expression and chronic glutamate toxicity in rat motor cortex. Neurobiol Dis (2007) 0.79
Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices. J Neurol Sci (2012) 0.78
DJ-1 mRNA anatomical localization and cell type identification in the mouse brain. Neurosci Lett (2009) 0.78
Reperfusion accelerates acute neuronal death induced by simulated ischemia. Exp Neurol (2007) 0.78
Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons. J Neurosci (2014) 0.78
Expression of NR2B in cerebellar granule cells specifically facilitates effect of motor training on motor learning. PLoS One (2008) 0.78
Self-assembled Peptide nanofibers designed as biological enzymes for catalyzing ester hydrolysis. ACS Nano (2014) 0.78
1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α. J Med Chem (2013) 0.77
Transcription factor AP-2β regulates the neurotransmitter phenotype and maturation of chromaffin cells. Mol Cell Neurosci (2010) 0.77
New thiazole carboxamides as potent inhibitors of Akt kinases. Bioorg Med Chem Lett (2011) 0.76
Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients. Neurocrit Care (2005) 0.76
DBS reduced hemichorea associated with a developmental venous anomaly and microbleeding in STN. Neurology (2014) 0.76